APLASTIC ANAEMIA

Introduction:

Aplastic anemia is a rare but serious condition in which the bone marrow fails to produce enough blood cells, including red blood cells (RBCs), white blood cells (WBCs), and platelets. This leads to pancytopenia—a deficiency of all three blood cell types. Aplastic anemia can be either acquired or inherited and is associated with bone marrow failure. Common causes include autoimmune destruction of hematopoietic stem cells, exposure to toxins, medications, viral infections, or radiation.

Pathophysiology:

  • Bone Marrow Failure: Aplastic anemia is caused by damage to the bone marrow stem cells, leading to insufficient production of RBCs, WBCs, and platelets. This can occur due to:

    • Autoimmune destruction: The immune system mistakenly attacks hematopoietic stem cells.

    • Toxins and drugs: Exposure to chemicals like benzene or certain medications (e.g., chemotherapy drugs, antibiotics like chloramphenicol) can cause bone marrow suppression.

    • Viral infections: Certain viruses (e.g., Epstein-Barr virus, hepatitis viruses, HIV, parvovirus B19) can lead to bone marrow damage.

    • Inherited disorders: Conditions like Fanconi anemia are genetic causes of aplastic anemia.

The destruction of bone marrow stem cells leads to reduced production of all blood cell lines:

  • Red blood cells: Resulting in anemia and oxygen-carrying impairment.

  • White blood cells: Resulting in increased susceptibility to infections.

  • Platelets: Leading to increased bleeding tendencies and bruising.

Specific Symptoms:

  • General anemia symptoms: Fatigue, weakness, pallor, shortness of breath, and dizziness due to low RBCs.

  • Bleeding symptoms: Easy bruising, nosebleeds, gum bleeding, petechiae (small red or purple spots), and prolonged bleeding from cuts due to thrombocytopenia (low platelets).

  • Infection-related symptoms: Recurrent infections, fevers, and slow healing of wounds due to leukopenia (low WBCs).

  • Palpitations, tachycardia, and potential heart failure in severe cases of anemia.

Treatment:

1. Pharmacological:

  • Immunosuppressive Therapy:

    • Anti-thymocyte globulin (ATG) and cyclosporine are used to suppress the immune system, particularly in cases where autoimmune mechanisms are believed to destroy bone marrow stem cells.

    • ATG targets and depletes T-cells, reducing the autoimmune attack on the bone marrow.

2. Non-Pharmacological:

  • Bone Marrow Transplant:

    • For younger patients or those with severe disease, a bone marrow (or stem cell) transplant from a matched donor is often the best curative option. It replaces the damaged bone marrow with healthy hematopoietic stem cells.

Lab Diagnosis:

  1. Complete Blood Count (CBC):

    • Pancytopenia: Low levels of all blood cell types (RBCs, WBCs, and platelets).

    • Hemoglobin (Hb): Decreased

    • Mean Corpuscular Volume (MCV): Normal or slightly elevated.

    • Reticulocyte count: Extremely low, reflecting the bone marrow's inability to produce new blood cells.

  2. Peripheral Blood Smear:

    • RBC Shape:

      • RBCs are typically normocytic (normal size) but present in reduced numbers.

      • Absence of immature blood cells (like reticulocytes) reflects bone marrow failure.

  3. Bone Marrow Biopsy:

    • A key diagnostic test. It shows hypocellular marrow with a marked reduction in hematopoietic cells and replacement by fat cells.

    • In contrast to normal marrow, aplastic anemia shows a lack of blood cell precursors.

  4. Tests for Infectious Agents:

    • Screening for viral infections (e.g., hepatitis, HIV, EBV) that might have caused the aplasia.

  5. Flow Cytometry:

    • In inherited forms, genetic testing may be performed (e.g., testing for Fanconi anemia).

Complications:

  • Severe infections: Due to the lack of white blood cells, patients are highly susceptible to life-threatening bacterial and fungal infections.

  • Hemorrhage: Low platelet counts lead to an increased risk of severe bleeding, which can result in intracranial hemorrhage or gastrointestinal bleeding.

  • Progression to other bone marrow disorders: Aplastic anemia may evolve into other conditions such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML).

  • Heart failure: Severe anemia can put a strain on the heart, leading to cardiomegaly (enlarged heart) and heart failure in prolonged cases.

  • Death: Without treatment, severe aplastic anemia is life-threatening due to the combined risks of infections, bleeding, and severe anemia.

Summary:

Aplastic anemia is a life-threatening condition caused by the failure of the bone marrow to produce adequate blood cells, leading to pancytopenia. It can be caused by autoimmune destruction, toxins, infections, or inherited conditions. Treatment may include immunosuppressive therapy or bone marrow transplantation. Diagnosis is based on blood tests showing pancytopenia and a bone marrow biopsy demonstrating hypocellularity. Without prompt treatment, aplastic anemia can lead to severe infections, bleeding, and other life-threatening complications.